Login / Signup

Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial.

Viviane Cordeiro VeigaJoão A G G PratsDanielle L C FariasRegis G RosaLeticia K DouradoFernando G ZampieriFlávia R MachadoRenato D LopesOtavio BerwangerLuciano C P AzevedoÁlvaro AvezumThiago C LisboaSalomón S O RojasJuliana C CoelhoRodrigo T LeiteJúlio C CarvalhoLuis E C AndradeAlex F SandesMaria C T PintãoClaudio G CastroSueli V SantosThiago M L de AlmeidaAndré N CostaOtávio C E GebaraFlávio G Rezende de FreitasEduardo S PachecoDavid J B MachadoJosiane MartinFábio G ConceiçãoSuellen R R SiqueiraLucas P DamianiLuciana M IshiharaDaniel SchneiderDenise de SouzaAlexandre B CavalcantiPhillip Scheinbergnull null
Published in: BMJ (Clinical research ed.) (2021)
ClinicalTrials.gov NCT04403685.
Keyphrases
  • coronavirus disease
  • study protocol
  • rheumatoid arthritis
  • juvenile idiopathic arthritis
  • early onset
  • rheumatoid arthritis patients
  • respiratory syndrome coronavirus
  • randomized controlled trial
  • clinical trial